We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current UBX market cap is 21.93M. The company's latest EPS is USD -2.7263 and P/E is -0.56.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -13.13M | -13.92M | -10.65M | -11.96M | -9.33M |
| Net Income | -13.71M | -14.17M | -10.87M | -12.21M | -15.29M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 33k | 4.78M | 236k | 0 |
| Operating Income | -91M | -91.3M | -56.67M | -57.57M | -39.07M |
| Net Income | -82.18M | -93.84M | -60.73M | -59.93M | -39.86M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 136.39M | 124.35M | 114.26M | 101.01M | 69.27M |
| Total Liabilities | 57.83M | 57.5M | 55.63M | 51.6M | 33.06M |
| Total Equity | 78.57M | 66.85M | 58.63M | 49.41M | 36.21M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 151.22M | 156.32M | 124.71M | 124.35M | 65.69M |
| Total Liabilities | 30.51M | 73.44M | 65.14M | 57.5M | 37.29M |
| Total Equity | 120.71M | 82.88M | 59.57M | 66.85M | 28.4M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -40.66M | -51.03M | -11.32M | -22.4M | -29.51M |
| Investing | -24.35M | -24.55M | 21.28M | 31.13M | 45.38M |
| Financing | 54.69M | 54.86M | 274k | -2.35M | -20.73M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -72.42M | -78.33M | -45.06M | -51.03M | -37.09M |
| Investing | 67.95M | -5.21M | 39.31M | -24.55M | 60.5M |
| Financing | 27.44M | 63.88M | 20.85M | 54.86M | -16.34M |
| Market Cap | 21.93M |
| Price to Earnings Ratio | -0.56 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.12 |
| Price to Book Ratio | 0.78 |
| Dividend Yield | - |
| Shares Outstanding | 14.62M |
| Average Volume (1 week) | 50.56k |
| Average Volume (1 Month) | 57.98k |
| 52 Week Change | -28.57% |
| 52 Week High | 3.82 |
| 52 Week Low | 1.46 |
| Spread (Intraday) | 0.09 (5.77%) |
| Company Name | UNITY Biotechnology Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.unitybiotechnology.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
